The Proteomics Core offers UCCC investigators access to analytical capabilities and the expertise to perform high-quality proteomic studies. The proteome is defined as the expressed protein complement of a fluid, cell, organ or organism. It is both time and region specific. Proteomics is the exercise of determining the proteome. The Proteomics Core assists with the identification of therapeutic targets, the elaboration of underlying mechanisms, and the identification of markers of cancer and anti-cancer therapies. Methods for protein and peptide isolation, separations, quantification, identification and bioinformatics analysis, together with expert guidance in study design, are integrated into the service offered by the Core. The Core has access to several analytical technologies thereby allowing investigators to adopt multiple strategies and to independently verify their findings. The Core also provides training in proteomics analysis and experimental design. Dr. Mark W. Duncan serves as Core Director and Dr. Kirk Hansen is the Manager at the main University of Colorado Denver Health Sciences facility and Katheryn Resing is the Director and Manager of the satellite facility at University of Colorado Boulder. Over the previous granting period the Proteomics Core Facilities were utilized by 25 Cancer Center members representing 7 out of 8 Cancer Center programs. Projects in the Core have centered on the qualitative and quantitative analysis of proteins and their isoforms in several cancers, including those of the lung, skin, thyroid and prostate. Additional mechanistic studies have also been undertaken. After review by the Oversight Committee and the Executive Committee the Core was restructured with the recruitment of Kirk Hansen as Core manager, and the adoption of a satellite facility housed on the Boulder campus. The last of these increases our capacity and adds special expertise in the characterization of post translational modification. The expansion of the facilities and personnel at the two sites has allowed for the institution of a number of new projects especially those evaluating new biomarkers in lung, breast, prostate and thyroid cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046934-23
Application #
8069533
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-02-01
Budget End
2011-01-31
Support Year
23
Fiscal Year
2010
Total Cost
$147,131
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Donson, Andrew M; Amani, Vladimir; Warner, Elliot A et al. (2018) Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma. Mol Cancer Ther 17:1984-1994
Branchford, B R; Stalker, T J; Law, L et al. (2018) The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. J Thromb Haemost 16:352-363
Pei, Shanshan; Minhajuddin, Mohammad; Adane, Biniam et al. (2018) AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells. Cell Stem Cell 23:86-100.e6
Ren, Shengxiang; Rivard, Christopher J; Yu, Hui et al. (2018) A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines. Clin Lung Cancer 19:450-456
Monks, Jenifer; Orlicky, David J; Stefanski, Adrianne L et al. (2018) Maternal obesity during lactation may protect offspring from high fat diet-induced metabolic dysfunction. Nutr Diabetes 8:18
Garcia, Tamara B; Fosmire, Susan P; Porter, Christopher C (2018) Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine. Leuk Res 64:30-33
Wahdan-Alaswad, R S; Edgerton, S M; Salem, H S et al. (2018) Metformin Targets Glucose Metabolism in Triple Negative Breast Cancer. J Oncol Transl Res 4:
Ryan, Weston Kenneth; Fernandez, Josiah; Peterson, Mikayla Katherine et al. (2018) Activation of S6 signaling is associated with cell survival and multinucleation in hyperplastic skin after epidermal loss of AURORA-A Kinase. Cell Death Differ :
Gadalla, Shahinaz M; Wang, Tao; Loftus, David et al. (2018) No association between donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia. Bone Marrow Transplant 53:383-391
Ghosh, Moumita; Miller, York E; Nakachi, Ichiro et al. (2018) Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 197:885-896

Showing the most recent 10 out of 1634 publications